Ibere Pharmaceuticals priced its upsized IPO of 12 million units at $10. per unit — 2 million more units than expected.
Units start trading today on the NYSE under IBERU. Each consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable at $11.50 for one share. Once the securities comprising the units begin separate trading, shares and warrants are expected to list under IBER and IBERW, respectively.
The SPAC intends to focus on opportunities in the pharmaceutical and life sciences industries. Read more.
